Clinical Trial Update: Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of the Leish-111f + MPL-SE vaccine in healthy adults not previously exposed to Leishmania has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Leish-111f + MPL-SE vaccine (Leish-111f with MPL-SE adjuvant)

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED